Table 3 Clinical outcome in the two groups (n = 395)
Event | SoC group (n = 188) | Intervention group (n = 207) | p* |
|---|---|---|---|
End of follow-up | |||
MACEs, No. (%) | 146 (77.8) | 116 (56.1) | < 0.001 |
All-cause death, No. (%) | 103 (54.8) | 86 (41.6) | 0.046 |
Myocardial infarction, No. (%) | 44 (23.4) | 32 (15.5) | < 0.001 |
Stroke, No. (%) | 28 (14.9) | 19 (9.2) | 0.002 |
Revascularization, No. (%) | 13 (6.9) | 16 (7.8) | 0.33 |
Major amputation, No. (%) | 3 (1.6) | 2 (0.9) | 0.5 |
Follow-up at end of intervention phase | |||
MACEs, No. (%) | 50 (26.6) | 24 (11.6) | 0.002 |